Dr. Mehmet Sitki Copur on the Most Exciting Research Presented at ASCO 2019

Video

Cancer Network spoke with Mehmet Sitki Copur, MD, FACP, medical oncologist at the Morrison Cancer Center, about the most exciting research presented at ASCO in 2019.

Cancer Network spoke with Mehmet Sitki Copur, MD, FACP, medical oncologist/hematologist at Mary Lanning Healthcare Center's Morrison Cancer Center, adjunct professor at the University of Nebraska Medical Center, and Editor-at-Large as well as a member of ONCOLOGY's Community Oncology Board, about the most exciting research presented at ASCO 2019.

Recent Videos
Marc S. Raab, MD, PhD, details how agents like carfilzomib may play a role in treatment after progression on teclistamab-based induction therapy.
The safety profile of teclistamab-based therapy in the MajesTEC-5 trial was expected based on the known compounds employed in each combination.
Related Content